CXCL6‐EGFR‐induced Kupffer cells secrete TGF‐β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C‐MYC/EZH2 pathway in liver fibrosis

Journal of Cellular and Molecular Medicine - Tập 22 Số 10 - Trang 5050-5061 - 2018
Xiaobo Cai1, Zhenghong Li1, Qidi Zhang1, Qu Yin1, Mingyi Xu1, Xinjian Wan1, Lungen Lu1
1Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Tóm tắt

AbstractLiver fibrosis is the excessive accumulation of extracellular matrix proteins in response to the inflammatory response that accompanies tissue injury, which at an advanced stage can lead to cirrhosis and even liver failure. This study investigated the role of the CXC chemokine CXCL6 (GCP‐2) in liver fibrosis. The expression of CXCL6 was found to be elevated in the serum and liver tissue of high stage liver fibrosis patients. Furthermore, treatment with CXCL6 (100 ng/mL) stimulated the phosphorylation of EGFR and the expression of TGF‐β in cultured Kupffer cells (KCs). Although treatment with CXCL6 directly did not activate the hepatic stellate cell (HSC) line, HSC‐T6, HSCs cultured with media taken from KCs treated with CXCL6 or TGF‐β showed increased expression of α‐SMA, a marker of HSC activation. CXCL6 was shown to function via the SMAD2/BRD4/C‐MYC/EZH2 pathway by enhancing the SMAD3‐BRD4 interaction and promoting direct binding of BRD4 to the C‐MYC promoter and CMY‐C to the EZH2 promoter, thereby inducing profibrogenic gene expression in HSCs, leading to activation and transdifferentiation into fibrogenic myofibroblasts. These findings were confirmed in a mouse model of CCl4‐induced chronic liver injury and fibrosis in which the levels of CXCL6 and TGF‐β in serum and the expression of α‐SMA, SMAD3, BRD4, C‐MYC, and EZH2 in liver tissue were increased. Taken together, our results reveal that CXCL6 plays an important role in liver fibrosis through stimulating the release of TGF‐β by KCs and thereby activating HSCs.

Từ khóa


Tài liệu tham khảo

10.1136/gutjnl-2014-306842

10.1016/j.jhep.2015.02.039

10.1016/j.jhep.2011.09.024

10.1002/cphy.c120035

10.1016/S0168-8278(99)80010-5

10.1097/BCR.0b013e318240541e

10.1111/j.1530-0277.1999.tb04202.x

Darby I, 1990, Alpha‐smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing, Lab Invest, 63, 21

10.1055/s-2005-858989

10.1074/jbc.274.52.37413

10.1074/jbc.274.38.27161

10.1038/37284

10.1016/S0014-4827(02)00015-0

10.1038/cddis.2016.434

10.1073/pnas.1522163112

10.1016/j.cell.2011.08.017

10.1073/pnas.1108190108

10.1038/nature10334

10.1053/j.gastro.2009.04.011

10.1158/1535-7163.MCT-15-0750

10.1074/jbc.M607705200

10.1189/jlb.0313140

10.1053/j.gastro.2009.01.056

10.1002/hep.22950

10.1111/j.1440-1746.2006.04650.x

10.3748/wjg.v12.i15.2357

10.1126/science.1079817

10.1002/path.2277

Wuyts A, 1996, Identification of mouse granulocyte chemotactic protein‐2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein‐2, J Immunol, 157, 1736, 10.4049/jimmunol.157.4.1736

10.1165/rcmb.2011-0260OC

10.1038/nrgastro.2015.200

10.1053/j.gastro.2014.06.043

10.1002/hep.24764

10.1053/j.gastro.2011.10.039

10.1002/hep.23894

10.1053/jhep.2002.33162

10.4049/jimmunol.1202909